PLANTATION, Fla., Dec. 29, 2023 /CNW/ - Akumin Inc. announced today that its Board of Directors has appointed Ronald J. Bienias, Akumin s Chief Restructuring Officer and Partner and Managing.
/PRNewswire/ Impel Pharmaceuticals Inc. (OTCQX: IMPL) ("Impel" or "the Company"), a commercial-stage biopharmaceutical company with a mission to develop.
Impel Pharmaceuticals Announces Filing Voluntary Chapter 11 Cases and Signing of Stalking Horse Agreement to Facilitate Sale Patient Access to Trudhesa® to.
Following the success of our Asset Tracing & Investigations breakfast series in 2022, we returned in 2023 with a host of new topics to share detailed insight on and discuss with our clients and attendees.